Market Cap 1.54B
Revenue (ttm) 450.71M
Net Income (ttm) -88.88M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 72.49
Profit Margin -19.72%
Debt to Equity Ratio -1.72
Volume 3,691,900
Avg Vol 2,941,724
Day's Range N/A - N/A
Shares Out 209.92M
Stochastic %K 1%
Beta 1.05
Analysts Strong Sell
Price Target $16.45

Company Profile

BioCryst Pharmaceuticals, Inc., a biotechnology company, develops oral small-molecule and injectable protein therapeutics to treat rare diseases. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat hereditary angioedema. It is also developing BCX17725, a protein therapeutic for netherton syndrome which is in phas...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 919 859 1302
Fax: 919 859 1314
Address:
4505 Emperor Boulevard, Suite 200, Durham, United States
ShortsHater
ShortsHater Oct. 4 at 6:48 PM
$BCRX might announce share buyback in the near future
1 · Reply
2YrsEarly
2YrsEarly Oct. 4 at 5:28 PM
$BCRX ENOUGH is ENOUGH! - 1.5B Market Cap - 400-450m cash on hand by year end - Term debt paid (frees up restrictions on cash) - BOD has a fiduciary duty to maximize shareholder value The #1 obvious fiduciary responsibility of the board is to stop the relentless destruction of the equity price. (Maximize shareholder value) The Institutional short-sellers have been sitting on the ask for years as they swallow up the bids and walk the stock price down. Now that the company finally has the means it’s time to go on offfense and put an end to this chaos by ANNOUNCING a $200M share Buyback. Shorts will have two choices: 1) Absorb the 28 million shares (13% of OS shares) at current price. 2) Cover and get the F*K out of the way! Both choices would be a win-win for the stock price. Shorts will choose #2 Now do your job BCRX mgmt and BOD and step up and do what’s right for your shareholders who have put up with all the BS over the years! P.S. Buy Out would be wonderful :)
1 · Reply
Fergus20
Fergus20 Oct. 4 at 4:19 PM
$PLTR hey all. Please bear with me as I am new to reading, but I think you should start putting every dollar you have into to $BCRX. It’s grossly undervalued. BioWar 2.0 is starting. This is maybe financial advice?
0 · Reply
Fergus20
Fergus20 Oct. 4 at 4:13 PM
$BCRX all of you are yag.
0 · Reply
Fergus20
Fergus20 Oct. 4 at 3:31 PM
$BCRX why aren’t the markets open today? Sorry, new to trading.
0 · Reply
Astronave
Astronave Oct. 4 at 2:51 PM
$BCRX Blackrock Vanguard and Avoro cut their holding in Bcrx, Avoro by half.
1 · Reply
TheYoungGeologist
TheYoungGeologist Oct. 4 at 2:37 PM
$BCRX looking at an entry around here, what do people think? Not sure how much further it can drop
1 · Reply
major_tom
major_tom Oct. 4 at 1:56 PM
$BCRX one explanation for increased institutional ownership could be averaging down?
2 · Reply
TheVulcanDevilWhale
TheVulcanDevilWhale Oct. 4 at 10:31 AM
0 · Reply
Paulzk
Paulzk Oct. 4 at 9:39 AM
$BCRX The S&P 500 Pharmaceuticals Index rallied 11% over the past five sessions, in its best weekly gain since July 2002 when drugmakers surged amid a flurry of positive news including FDA approvals and better-than-expected quarterly reports. https://finance.yahoo.com/news/pharma-stocks-eye-best-week-132807753.html
1 · Reply
Latest News on BCRX
BioCryst: Blue Light Special In Small Cap Biotech Aisle

Sep 29, 2025, 2:53 AM EDT - 5 days ago

BioCryst: Blue Light Special In Small Cap Biotech Aisle


BioCryst to Present at Upcoming Investor Conference

Aug 21, 2025, 7:00 AM EDT - 6 weeks ago

BioCryst to Present at Upcoming Investor Conference


BioCryst Announces Departure of Dr. Helen Thackray

Aug 11, 2025, 7:00 AM EDT - 7 weeks ago

BioCryst Announces Departure of Dr. Helen Thackray


ORLADEYO® (berotralstat) Approved in Colombia

Jun 13, 2025, 7:00 AM EDT - 4 months ago

ORLADEYO® (berotralstat) Approved in Colombia


BioCryst to Present at Upcoming Investor Conferences

May 27, 2025, 7:00 AM EDT - 4 months ago

BioCryst to Present at Upcoming Investor Conferences


BioCryst: Strong Opportunity For A Double With A Proven Therapy

May 5, 2025, 2:05 PM EDT - 5 months ago

BioCryst: Strong Opportunity For A Double With A Proven Therapy


BioCryst Appoints Steve Frank to Board of Directors

May 1, 2025, 7:00 AM EDT - 5 months ago

BioCryst Appoints Steve Frank to Board of Directors


BioCryst to Report First Quarter 2025 Financial Results on May 5

Apr 21, 2025, 7:00 AM EDT - 5 months ago

BioCryst to Report First Quarter 2025 Financial Results on May 5


BioCryst: Orladeyo's Expansion Is Just Getting Started

Feb 26, 2025, 9:09 AM EST - 7 months ago

BioCryst: Orladeyo's Expansion Is Just Getting Started


BioCryst Launches ORLADEYO® (berotralstat) in Portugal

Feb 12, 2025, 7:00 AM EST - 8 months ago

BioCryst Launches ORLADEYO® (berotralstat) in Portugal


BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy

Dec 9, 2024, 1:47 PM EST - 10 months ago

BioCryst Pharmaceuticals: Seasoned Blockbuster Makes It A Buy


BioCryst Launches ORLADEYO® (berotralstat) in Ireland

Nov 18, 2024, 2:00 AM EST - 11 months ago

BioCryst Launches ORLADEYO® (berotralstat) in Ireland


ShortsHater
ShortsHater Oct. 4 at 6:48 PM
$BCRX might announce share buyback in the near future
1 · Reply
2YrsEarly
2YrsEarly Oct. 4 at 5:28 PM
$BCRX ENOUGH is ENOUGH! - 1.5B Market Cap - 400-450m cash on hand by year end - Term debt paid (frees up restrictions on cash) - BOD has a fiduciary duty to maximize shareholder value The #1 obvious fiduciary responsibility of the board is to stop the relentless destruction of the equity price. (Maximize shareholder value) The Institutional short-sellers have been sitting on the ask for years as they swallow up the bids and walk the stock price down. Now that the company finally has the means it’s time to go on offfense and put an end to this chaos by ANNOUNCING a $200M share Buyback. Shorts will have two choices: 1) Absorb the 28 million shares (13% of OS shares) at current price. 2) Cover and get the F*K out of the way! Both choices would be a win-win for the stock price. Shorts will choose #2 Now do your job BCRX mgmt and BOD and step up and do what’s right for your shareholders who have put up with all the BS over the years! P.S. Buy Out would be wonderful :)
1 · Reply
Fergus20
Fergus20 Oct. 4 at 4:19 PM
$PLTR hey all. Please bear with me as I am new to reading, but I think you should start putting every dollar you have into to $BCRX. It’s grossly undervalued. BioWar 2.0 is starting. This is maybe financial advice?
0 · Reply
Fergus20
Fergus20 Oct. 4 at 4:13 PM
$BCRX all of you are yag.
0 · Reply
Fergus20
Fergus20 Oct. 4 at 3:31 PM
$BCRX why aren’t the markets open today? Sorry, new to trading.
0 · Reply
Astronave
Astronave Oct. 4 at 2:51 PM
$BCRX Blackrock Vanguard and Avoro cut their holding in Bcrx, Avoro by half.
1 · Reply
TheYoungGeologist
TheYoungGeologist Oct. 4 at 2:37 PM
$BCRX looking at an entry around here, what do people think? Not sure how much further it can drop
1 · Reply
major_tom
major_tom Oct. 4 at 1:56 PM
$BCRX one explanation for increased institutional ownership could be averaging down?
2 · Reply
TheVulcanDevilWhale
TheVulcanDevilWhale Oct. 4 at 10:31 AM
0 · Reply
Paulzk
Paulzk Oct. 4 at 9:39 AM
$BCRX The S&P 500 Pharmaceuticals Index rallied 11% over the past five sessions, in its best weekly gain since July 2002 when drugmakers surged amid a flurry of positive news including FDA approvals and better-than-expected quarterly reports. https://finance.yahoo.com/news/pharma-stocks-eye-best-week-132807753.html
1 · Reply
Magnificient
Magnificient Oct. 4 at 9:28 AM
$BCRX Ooof Stoney what did you to your own Company? Must read about catalysts. But bo would be the best solution here
0 · Reply
Fergus20
Fergus20 Oct. 4 at 2:11 AM
$PLTR the most overvalued company on earth besides $BCRX
0 · Reply
Fergus20
Fergus20 Oct. 4 at 2:04 AM
$BCRX omfg! So damn strong after hours!
0 · Reply
Smnorgy1
Smnorgy1 Oct. 4 at 1:36 AM
$BCRX So ThinkingCow, what's the upside? Computer skeptic, cause above my head, to open mind. Fundamentals considered beyond programs, what coming??.
0 · Reply
Ttubular
Ttubular Oct. 4 at 12:32 AM
$BCRX do we really go below $7 next week? 1.5 billion MC for BCRX is crazy low. Problem one of the most undervalued BIO stocks around. If it goes under I will be adding big time.
1 · Reply
Fergus20
Fergus20 Oct. 4 at 12:29 AM
$BCRX it’s bull flagging!!! -Every idiot here
0 · Reply
Fergus20
Fergus20 Oct. 4 at 12:29 AM
$BCRX the chart looks so unbelievably strong
0 · Reply
2YrsEarly
2YrsEarly Oct. 3 at 11:25 PM
$BCRX Did everyone survive the beating again this week?
0 · Reply
Dpst2022
Dpst2022 Oct. 3 at 10:49 PM
$BCRX @BirdStar is the type of bitch to complain about a wrong order at a fast food restaurant, but stay quiet when his 5 figure BCRX investment goes down the drain every year for three years.
0 · Reply
Ttubular
Ttubular Oct. 3 at 10:45 PM
$BCRX our roller coaster ride seems to only go down
1 · Reply
Dpst2022
Dpst2022 Oct. 3 at 10:38 PM
$BCRX @BirdStar says that Complaining is for bitches apparently. I see a lot of complaining on the board lately.
0 · Reply
Forec4
Forec4 Oct. 3 at 10:37 PM
0 · Reply